Harvard Bioscience (HBIO) Tops Q1 EPS by 2c
FREE Breaking News Alerts from StreetInsider.com!
StreetInsider.com Top Tickers, 10/26/2026
- Equities end higher as Anthropic's IPO filing buoys AI stocks
- Anthropic files for Nasdaq IPO as revenue jumps to $16.3 billion
- Meta reverses losses to rise as investors weigh $35 billion AI funding plan
- Post-election relief ahead for markets, says Morgan Stanley
- Musk says SpaceX raised $40 billion in debt, warns of neocloud collapse
Tweet
Share
E-mailGet Alerts HBIO Hot Sheet
Price: $8.32 +1.09%
Revenue Growth %: +6.1%
Financial Fact:
Gross Profit: 11.69M
Today's EPS Names:
SICP, OMID, ELME, More
Revenue Growth %: +6.1%
Financial Fact:
Gross Profit: 11.69M
Today's EPS Names:
SICP, OMID, ELME, More
Join SI Premium – FREE
Harvard Bioscience (NASDAQ: HBIO) reported Q1 EPS of $0.06, $0.02 better than the analyst estimate of $0.04. Revenue for the quarter came in at $30 million versus the consensus estimate of $28.95 million.
For earnings history and earnings-related data on Harvard Bioscience (HBIO) click here.
Serious News for Serious Traders! Try StreetInsider.com Premium Free!
You May Also Be Interested In
- Can JetBlue still avoid bankruptcy? Analysis says yes, but it won’t be easy
- Welltower (WELL) Misses Q3 EPS by 11c; raises guidance
- Custom Truck One Source, Inc. (CTOS) Reports In-Line Q3 EPS, Misses on Revenue
Create E-mail Alert Related Categories
EarningsRelated Entities
EarningsSign up for StreetInsider Free!
Receive full access to all new and archived articles, unlimited portfolio tracking, e-mail alerts, custom newswires and RSS feeds - and more!
